cancer and semaglutide Clinical Impact of Beyond Glycemic Control: A Critical Analysis of Oncogenic Potential Mitigation of Cardiotoxicity GLP-1 Weight Loss Drugs Linked

doi: 10.1038/s41467-024-52528-7 98 WangFJinYWangMLuoH-YFangW-JWangY-Net al

"Many individuals consume excess calories while still failing to meet their daily protein needs and this becomes critically important during GLP-1 therapy, bariatric surgery, and metabolic dysfunction." Protein is not a macronutrient it is the structural material your body uses to preserve lean muscle, regulate appetite hormones, support immune function, and maintain metabolic rate

Patients with prior cardiac issues should be cautioned further

Strappazzon F, Vietri-Rudan M, Campello S, Nazio F, Florenzano F, Fimia GM, et al

For injectable: no reliable timeline because no good trial data exists

CLICK HERE TO SIGN UP FOR OUR HEALTH NEWSLETTER Severe obesity can also present physical barriers during intimacy, as weight loss improves mobility and comfort